Focused ultrasound to help veterans with PTSD
Official title: Low Intensity Focused Ultrasound for Posttraumatic Stress Disorder
Run by VA Office of Research and Development · NCT06820138 · Data updated 2026-11-12
This study tests a non-invasive brain treatment using low intensity focused ultrasound to see if it can reduce PTSD symptoms and improve daily functioning in veterans.
Quick facts
| Phase | Phase 2 |
|---|---|
| Study type | Interventional |
| Ages | 22 Years to 70 Years |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | VA Office of Research and Development Federal |
| Locations | 1 site (Providence, Rhode Island) |
| Status | Recruiting |
| Started | September 9, 2026 |
| Main results expected | December 31, 2029 |
| Study ends | March 29, 2030 |
| Registry record updated | September 15, 2026 |
| Trial ID | NCT06820138 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Veterans with DSM-5-confirmed chronic PTSD who are currently symptomatic and, if on treatment, stable on their psychiatric medications.
✕Probably not a fit
Individuals with contraindications to ultrasound or neuroimaging, recent brain injury, certain implants, or serious comorbid conditions may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a Phase 2, dose-finding study testing low intensity focused ultrasound (FUS) delivered to the amygdala for PTSD in veterans. The trial aims to determine whether FUS can improve symptom severity and functional disability over one month, with attention to safety and short- and longer-term effects. Participants are Veterans with chronic PTSD who are stable on psychiatric treatment if applicable. The intervention uses a Brainsonix ultrasound device to target deep brain regions non-invasively, contrasting with high-intensity approaches that cause tissue ablation. Eligibility excludes individuals with certain neurologic conditions, recent brain injury, active substance use issues, metal in the head, or implants that contraindicate ultrasound or neuroimaging.
Why it matters
Potential benefit: If successful, participants may experience reduced PTSD symptoms and better daily functioning due to targeted brain modulation.
How similar studies have gone: Previous first-in-human work with FUS for PTSD or related conditions showed feasibility; this study expands to a larger, dose-finding Phase 2.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: -Veterans ages who meet DSM-5 criteria for chronic Post-traumatic stress disorder (PTSD) using the Clinician Administered PTSD Scale for DSM-5 (CAPS-5) and currently symptomatic. If applicable, Veterans will be required to be on stable psychiatric treatment(s) prior to baseline assessments Exclusion Criteria: * contraindications to focused ultrasound and/or neuroimaging: * i) history of seizure disorder or serious neurologic illness including dementia or serious cognitive impairment, * ii) structural or neurologic abnormalities present or in close proximity to sonication site * iii) prior brain surgery * iv) pacemaker or implanted central nervous system device * v) greater than mild traumatic brain injury, or any head injury within sixty days of ultrasound * vi) greater than moderate alcohol or substance use disorders or active use or withdrawal from alcohol or substances * vii) metal in the head * viii) physical impediment likely to interfere with assessments, or * ix) unable to follow protocols * x) Veterans with significant white matter findings or those with findings in the beam of the ultrasound may also be excluded at discretion of study staff * Veterans with acute suicidality are also excluded
Where it's running
-
Providence VA Medical Center, Providence, RI
Providence, Rhode Island, United States Recruiting
Study contacts
- Principal investigator: Noah S. Philip, MD — Providence VA Medical Center, Providence, RI
- Study coordinator: Noah S Philip, MD
- Email: noah.philip@va.gov
- Phone: (401) 273-7100
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Reboxetine plus Ritalin vs Dog-Assisted Therapy for PTSD
This study tests whether a drug combo of reboxetine and methylphenidate works better than dog-assisted therapy for people with PTSD.
-
Self-Help CPT with WoVeN Peer Support for Women Veterans with PTSD
This study tests a self-help Cognitive Processing Therapy and a WoVeN peer-support program, alone and together, to see if they improve PTSD symptoms and well-being for women veterans.
-
Adaptive, personalized PTSD care for veterans
This program will try different therapy sequences plus optional text-message homework reminders to see if switching treatments or sending prompts helps veterans with PTSD who aren't improving or are missing between-session homework.
-
Multi‑Mode Cognitive Processing Therapy for adults with PTSD
This program will try a multi‑mode form of Cognitive Processing Therapy to reduce PTSD symptoms and improve sleep and mood in adults aged 20–65 with PTSD.
-
Improving thinking, daily functioning, mood, and sleep after mild traumatic brain injury and PTSD
This project will test whether adding morning bright light therapy to compensatory cognitive training helps post-9/11 Veterans with mild traumatic brain injury and PTSD think, function, and sleep better compared with a neutral ion generator.
-
Combined MDMA and psilocybin treatment for Veterans with PTSD
This trial tests whether giving MDMA followed 30 minutes later by psilocybin can be safely used to reduce symptoms in military veterans with long-standing PTSD.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.